Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Ginkgo Bioworks Holdings, Inc.

Get SEC filing alerts via email and in your feed for Ginkgo Bioworks Holdings, Inc.

DNA DNA-WT DNABW

Ginkgo Bioworks Holdings, Inc.

About Ginkgo Bioworks Holdings, Inc.

Ginkgo BioWorks is a biotechnology company specializing in cell engineering and biosecurity. It provides R&D services, tools, and platforms to develop biologics, gene therapies, vaccines, and agricultural solutions. Its core value lies in making biology easier to engineer through automation, AI, and data assets, serving industries like pharmaceuticals, agriculture, industrial biotech, and government, with a focus on innovation, scalability, and biosecurity.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Ginkgo Bioworks Holdings, Inc.

1
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports 49% Revenue Decline and $82.6 Million Net Loss in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports Revenue Decline to $170.2 Million and Net Loss of $312.8 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports 56.5% Revenue Decline in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports $49.6M Revenue in Q2 2025, Down 11.7% Year-Over-Year

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports $48.3 Million Revenue in Q1 2025, 27% Increase Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports $547M Net Loss for Fiscal Year 2024, Implements Major Restructuring

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Reports Q3 2024 Financial Results: Revenue Growth, Expense Reduction, and Net Loss Improvement

Via official filing (AI summary) | over 1 year ago | 0 comments